Integra LifeSciences Holdings Corporation

IART
29,18
0,01 (0,03%)
01 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:20GLOBEIntegra LifeSciences to Spotlight CereLink® Intracranial..
18/4/202423:24GLOBEIntegra LifeSciences to Reschedule the First Quarter 2024..
01/4/202422:15GLOBEIntegra LifeSciences Completes the Acquisition of Acclarent,..
11/3/202413:30GLOBEIntegra LifeSciences Launches MicroMatrix® Flex to Provide..
08/3/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:53EDGAR2Form 144 - Report of proposed sale of securities
28/2/202412:15EDGAR2Form 8-K - Current report
28/2/202412:10EDGAR2Form 8-K - Current report
28/2/202412:00GLOBEIntegra LifeSciences Announces Leadership Transition Plan
27/2/202423:15EDGAR2Form 8-K/A - Current report: [Amend]
22/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202421:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202423:49EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202415:15GLOBEIntegra LifeSciences to Host Fourth Quarter and Full Year..
19/1/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:30GLOBEIntegra LifeSciences to Present at the 42nd Annual J.P...
20/12/202322:57EDGAR2Form 8-K - Current report
13/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/12/202322:31EDGAR2Form 8-K - Current report
13/12/202313:03DJNIntegra LifeSciences to Buy Acclarent From Johnson & Johnson
13/12/202312:30EDGAR2Form 8-K - Current report
13/12/202312:15GLOBEIntegra LifeSciences Announces Definitive Agreement to..
12/12/202318:00GLOBEIntegra LifeSciences Appoints Jeff Graves, Ph.D., to Board..
07/11/202319:54PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
03/11/202321:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202303:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
31/10/202310:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
25/10/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/10/202312:15EDGAR2Form 8-K - Current report
25/10/202312:00GLOBEIntegra LifeSciences Reports Third Quarter 2023 Financial..
24/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/10/202304:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
17/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
13/10/202322:25EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
10/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
05/10/202304:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
04/10/202314:00GLOBEIntegra LifeSciences to Host Third Quarter 2023 Financial..
03/10/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
05/9/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/9/202323:04GLOBEIntegra LifeSciences to Present at the 2023 Wells Fargo..
10/8/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202323:54EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 29,21 Min: 29,061 Max: 29,96
Chiusura: 29,17

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network